Found 55 matching trials
A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma PHASE3 This study will assess the efficacy and safety of mosunetuzumab in combinat...
Show More Status
Active Not Recruiting
Location
City of Hope Cancer Center
Learn More & Join Trial
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE2 This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Show More Location
Banner University Medical Center - Tucson
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma PHASE3 This study will evaluate the efficacy and safety of mosunetuzumab in combin...
Show More Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma PHASE2 BrUOG-401 is a prospective, single-arm, phase 2 trial of first-line therapy...
Show More Location
Yale Cancer Center
Learn More & Join Trial
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies PHASE2 This study will evaluate the efficacy, safety, and pharmacokinetics of mosu...
Show More Status
Active Not Recruiting
Location
Infirmary Cancer Care
Learn More & Join Trial
Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma PHASE2 The purpose of this study is to test a new medication called Mosunetuzumab ...
Show More Location
University of Miami
Learn More & Join Trial
Mosunetuzumab for CLL MRD Clearance PHASE1 The goal of this study is to test mosunetuzumab given alone or in combinati...
Show More Location
Brigham & Women's Hospital
Learn More & Join Trial
Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5 PHASE3 This study is a phase III, randomized, open-label, international, multicent...
Show More Location
Krankenhaus der Barmherzigen BrĂŒder Graz - Abteilung FĂŒr Innere Medizin I
Learn More & Join Trial
A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer. PHASE1 This trial will study how safely the tazemetostat works with other therapie...
Show More Location
California Cancer Associates For Research And Excellence, cCARE
Learn More & Join Trial
Trial to Evaluate Efficacy and Safety of Subcutaneous Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma . PHASE2 This is a multi-center, open-label, interventional clinical trial designed ...
Show More Location
Rambam Health Care Campus
Learn More & Join Trial